In a study assessing Trop-2 expression in 94 breast cancers (luminal A, luminal B, HER2-positive, and triple-negative subtypes), no statistically significant differences in Trop-2 expression were observed between the groups. The gene discussed is TACSTD2; the disease is breast cancer.